SCHEMBL1605384

SCHEMBL1605384

CCCCCCCCCCCCCCCCCCC=C(C)C(=O)OCCN(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 5/20 0.54
TSHR P16473 2/20 0.42
EP300 Q09472 1/20 0.41
LSS P48449 1/20 0.41
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRM3 P20309 1/20 0.40
CHRNA4 P43681 1/20 0.40
NAAA Q02083 1/20 0.39
FAAH O00519 3/20 0.38
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.37
MAOA P21397 1/20 0.37
CNR1 P21554 1/20 0.37
DRD4 P21917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27677235 1.00 DNM1 (0.54) DNM1TSHREP300LSSESR1
SCHEMBL27353543 1.00 DNM1 (0.54) DNM1TSHREP300LSSESR1
Bromide SCHEMBL28102956 0.97 DNM1 (0.51) DNM1TSHREP300LSSESR1
Bromide SCHEMBL28784829 0.97 DNM1 (0.51) DNM1TSHREP300LSSESR1
SCHEMBL12610060 0.94 DNM1 (0.49) DNM1TSHRLSSESR1ESR2
SCHEMBL8349323 0.88 TSHR (0.50) DNM1TSHRLSSNAAAFAAH
SCHEMBL27937213 0.88 TSHR (0.50) DNM1TSHRLSSNAAAFAAH
SCHEMBL5586187 0.88 TSHR (0.50) DNM1TSHRLSSNAAAFAAH
SCHEMBL28027536 0.87 CHRM2 (0.44) DNM1TSHRLSSCHRM2CHRM4
Hydrochloric Acid SCHEMBL28935528 0.87 TSHR (0.49) DNM1TSHRLSSNAAAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115671375-A Emulsion-enhanced viscosity-increasing drug-loaded hydrogel dressing and preparation method thereof 中国人民解放军空军军医大学 2023-02-03 CN claimed
EP-1613302-B1 PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO PROCYTE CORP (US) 2009-12-23 EP claimed
EP-1585496-B1 COSMETIC COMPOSITION COMPRISING QUATERNIZED LANOLIN COLGATE PALMOLIVE CO (US) 2009-09-16 EP claimed
US-7012050-B2 Skin cleansing composition comprising a quaternized lanolin COLGATE-PALMOLIVE COMPANY (US) 2006-03-14 US claimed
US-12013574-B2 Stable microcapsule compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2024-06-18 US disclosed
CN-118175983-A Hair treatment composition 莱雅公司 2024-06-11 CN disclosed
CN-118040227-A Composite diaphragm for providing SEI film with high mechanical strength, preparation method thereof and application thereof in lithium metal battery 哈尔滨工业大学 2024-05-14 CN disclosed
US-20240004145-A1 Stable Microcapsule Compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. 2024-01-04 US disclosed
EP-4209264-A1 MICROCAPSULE COMPOSITIONS STABILIZED WITH VISCOSITY CONTROL AGENTS International Flavors & Fragrances Inc. (US) 2023-07-12 EP disclosed
EP-3512625-B1 MICROCAPSULE COMPOSITIONS STABILIZED WITH VISCOSITY CONTROL AGENTS INT FLAVORS & FRAGRANCES INC (US) 2023-04-26 EP disclosed
US-20230046103-A1 Stable Microcapsule Compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. 2023-02-16 US disclosed
CN-115671375-A Emulsion-enhanced viscosity-increasing drug-loaded hydrogel dressing and preparation method thereof 中国人民解放军空军军医大学 2023-02-03 CN disclosed
CN-1238000-A Concentrated quaternary ammonium fabric softener compositions containing cationic polymers PROCTER & GAMBLE (US) 1999-12-08 CN disclosed
EP-0931132-A1 CONCENTRATED QUATERNARY AMMONIUM FABRIC SOFTENER COMPOSITIONS CONTAINING CATIONIC POLYMERS THE PROCTER & GAMBLE COMPANY (US) 1999-07-28 EP disclosed
WO-1999006509-A1 CONCENTRATED, STABLE, PREFERABLY CLEAR, FABRIC SOFTENING COMPOSITION CONTAINING AMINE FABRIC SOFTENER THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed
CN-1203526-A Personal cleansing composition COLGATE PALMOLIVE CO (US) 1998-12-30 CN disclosed
EP-0858321-A1 PERSONAL CLEANSING COMPOSITION Colgate-Palmolive Company (US) 1998-08-19 EP disclosed
WO-1998012293-A1 CONCENTRATED QUATERNARY AMMONIUM FABRIC SOFTENER COMPOSITIONS CONTAINING CATIONIC POLYMERS THE PROCTER & GAMBLE COMPANY (US) 1998-03-26 WO disclosed
WO-1997016168-A1 PERSONAL CLEANSING COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 1997-05-09 WO disclosed
US-5627149-A PERSONAL CARE PRODUCT WITH ANIONIC AND CATIONIC SURFACTANT FOR HAIR OR SKIN COSMETICS COLGATE PALMOLIVE COMPANY (US) 1997-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12013574-B2 Stable microcapsule compositions LIPA, AUP1, PHOSPHO1 DNM1 3048/4885TSHR 4498/4885EP300 573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.